Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (171-180 of 244) with videos related to

Pageof 25
Sort By:
Neurobiology of Disease|September 10, 2005
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtinYuji Tanaka, Shuichi Igarashi, Masayuki Nakamura, et al.
Movement Disorders Clinical Practice|September 21, 2019
Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic CategoriesChristopher A Ross, Ralf Reilmann, Francisco Cardoso, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 25, 2005
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formationKah Leong Lim, Katherine C M Chew, Jeanne M M Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylationLaura E Bowie, Tamara Maiuri, Melanie Alpaugh, et al.
The Lancet. Neurology|December 3, 2014
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational studyJane S Paulsen, Jeffrey D Long, Christopher A Ross, et al.
Human Molecular Genetics|June 29, 2022
Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathwayYi Huang, Heng Huang, Leping Zhou, et al.
Journal of Neurochemistry|April 24, 2010
Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar ParkinsonismMali Jiang, Yair Porat-Shliom, Zhong Pei, et al.
Nature Communications|February 15, 2017
Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's diseaseRocio Gomez-Pastor, Eileen T Burchfiel, Daniel W Neef, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2015
Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12Elizabeth E O'Hearn, Hyon S Hwang, Susan E Holmes, et al.
Human Molecular Genetics|October 19, 2019
Physiological and pathological roles of LRRK2 in the nuclear envelope integrityVered Shani, Hazem Safory, Raymonde Szargel, et al.
Pageof 25

Showing results (171-180 of 244) with videos related to

Sort By:
Pageof 25
Neurobiology of Disease|September 10, 2005
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtinYuji Tanaka, Shuichi Igarashi, Masayuki Nakamura, et al.
Movement Disorders Clinical Practice|September 21, 2019
Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic CategoriesChristopher A Ross, Ralf Reilmann, Francisco Cardoso, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 25, 2005
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formationKah Leong Lim, Katherine C M Chew, Jeanne M M Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2018
N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylationLaura E Bowie, Tamara Maiuri, Melanie Alpaugh, et al.
The Lancet. Neurology|December 3, 2014
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational studyJane S Paulsen, Jeffrey D Long, Christopher A Ross, et al.
Human Molecular Genetics|June 29, 2022
Mutant VPS35-D620N induces motor dysfunction and impairs DAT-mediated dopamine recycling pathwayYi Huang, Heng Huang, Leping Zhou, et al.
Journal of Neurochemistry|April 24, 2010
Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar ParkinsonismMali Jiang, Yair Porat-Shliom, Zhong Pei, et al.
Nature Communications|February 15, 2017
Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's diseaseRocio Gomez-Pastor, Eileen T Burchfiel, Daniel W Neef, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2015
Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12Elizabeth E O'Hearn, Hyon S Hwang, Susan E Holmes, et al.
Human Molecular Genetics|October 19, 2019
Physiological and pathological roles of LRRK2 in the nuclear envelope integrityVered Shani, Hazem Safory, Raymonde Szargel, et al.
Pageof 25